Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders
TOKYO & KAWASAKI, Japan--(BUSINESS WIRE)--#proteindegrader--Astellas Pharma Inc. (TOKYO: 4503, President and CEO: Naoki Okamura, “Astellasâ€)…